Sabra Health Care REIT, Inc. (SBRA) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 16, 2026
Summary
Sabra Health Care REIT’s revenue went from $261M in fiscal 2016 to $775M in fiscal 2025, growth of about 12.9% a year.
Net income in fiscal 2025 was $156M, a net margin of 20.1%; the best year in this period was 2018 with $279M.
Over the twelve months to September 30, 2026, revenue was $919M and net income $72M.
Free cash flow was -$104M in fiscal 2025 and positive in 8 of the 10 years shown.
The diluted share count rose 273% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $919M | $775M | $703M | $648M | $625M | $570M | $599M | $662M | $623M | $408M | $261M |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | $65M | — | — | — | — | — | — | — | — | — | — |
| Net income | $72M | $156M | $127M | $14M | -$78M | -$113M | $138M | $69M | $279M | $158M | $70M |
| EPS (diluted) | $0.28 | $0.64 | $0.54 | $0.06 | $-0.34 | $-0.52 | $0.67 | $0.37 | $1.51 | $1.40 | $0.92 |
| R&D | — | — | — | — | — | — | — | — | — | — | — |
| Revenue growth | — | +10.2% | +8.6% | +3.6% | +9.7% | −4.9% | −9.6% | +6.2% | +52.7% | +56.7% | +9.1% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $401M | $349M | $311M | $301M | $316M | $356M | $355M | $372M | $361M | $136M | $176M |
| Capital spending | -$668M | -$453M | -$136M | -$79M | -$92M | -$99M | -$93M | -$51M | -$262M | -$420M | -$154M |
| Free cash flow | -$267M | -$104M | $174M | $222M | $224M | $257M | $262M | $321M | $99M | -$284M | $22M |
| Dividends paid | $303M | $289M | $280M | $277M | $277M | $263M | $278M | $335M | $325M | $182M | $119M |
| Buybacks | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based pay | $14M | $11M | $9M | $8M | $7M | $8M | $8M | $10M | $8M | $8M | $7M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $72M | $60M | $41M | $49M | $112M | $59M | $39M | $50M | $519M | $26M |
| Debt | — | $2.5B | $2.4B | $2.4B | $2.5B | $2.4B | $2.4B | $2.4B | $3.2B | $3.4B | $1.2B |
| Equity | — | $2.8B | $2.7B | $2.8B | $3.1B | $3.4B | $3.4B | $3.5B | $3.3B | $3.4B | $1.0B |
| Total assets | — | $5.5B | $5.3B | $5.4B | $5.7B | $6.0B | $6.0B | $6.1B | $6.7B | $7.0B | $2.3B |
| Shares (diluted) | 260M | 244M | 236M | 233M | 231M | 219M | 207M | 188M | 179M | 106M | 66M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | — | — | — | — |
| Operating margin | 7.1% | — | — | — | — | — | — | — | — | — | — |
| Net margin | 7.8% | 20.1% | 18.0% | 2.1% | -12.4% | -19.9% | 23.1% | 10.4% | 44.8% | 38.8% | 27.0% |
| FCF margin | -29.1% | -13.5% | 24.8% | 34.3% | 35.8% | 45.1% | 43.8% | 48.6% | 15.9% | -69.6% | 8.6% |
| ROIC | — | — | — | — | — | — | — | — | — | — | — |
| ROE | — | 5.5% | 4.6% | 0.5% | -2.5% | -3.4% | 4.1% | 2.0% | 8.6% | 4.6% | 6.9% |
Frequently asked questions
What is Sabra Health Care REIT’s annual revenue?
$775M in fiscal 2025 and $919M over the twelve months to September 30, 2026.
How much profit does Sabra Health Care REIT make?
Net income was $156M in fiscal 2025 (net margin 20.1%).
Is Sabra Health Care REIT’s revenue growing?
Yes: revenue rose 10.2% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.